Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Koen Vercauteren"'
Autor:
Elise De Vos, Liesbeth Van Gestel, Isabel Brosius, Chris Kenyon, Bea Vuylsteke, Irith De Baetselier, Joachim Mariën, Eugene Bangwen, Simon Couvreur, Amaryl Lecompte, Dominique Van Beckhoven, Bart Hoorelbeke, Babs E. Verstrepen, Luca M. Zaeck, Rory D. de Vries, Corine H. Geurts van Kessel, Niel Hens, Kevin K. Ariën, Koen Vercauteren, Marjan Van Esbroek, Christophe Van Dijck, Laurens Liesenborghs
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107132- (2024)
Objectives: The 2022 mpox epidemic reached a peak in Belgium and the rest of Europe in July 2022, after which it unexpectedly subsided. This study investigates epidemiological, behavioral, and immunological factors behind the waning of the epidemic i
Externí odkaz:
https://doaj.org/article/9a9479be314843b0af158049f45afc84
Autor:
Ole Lagatie, Dax Lauwers, Harvinder Singh, Fien Vanroye, Daniel J. Stieh, Johan Vingerhoets, Ludo Lavreys, Valérie Oriol-Mathieu, Will Colón, Chris Verhofstede, Koen Vercauteren, Dorien Van den Bossche, Maria Grazia Pau
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Vaccine-induced seroreactivity/positivity (VISR/P) poses a significant and common challenge to HIV vaccine implementation, as up to 95% of vaccine recipients may be misclassified as having HIV infection by current HIV screening and confirmat
Externí odkaz:
https://doaj.org/article/e8573c55271245db8ae647201e18486b
Autor:
Laurens Liesenborghs, Jasmine Coppens, Christophe Van Dijck, Isabel Brosius, Irith De Baetselier, Koen Vercauteren, Marjan Van Esbroeck
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 2, Pp 402-402 (2024)
Externí odkaz:
https://doaj.org/article/1ffe5845e88e469b83ce1e85c56376f3
Autor:
Anna Postovskaya, Alexandra Vujkovic, Tessa de Block, Lida van Petersen, Maartje van Frankenhuijsen, Isabel Brosius, Emmanuel Bottieau, Christophe Van Dijck, Caroline Theunissen, Sabrina H. van Ierssel, Erika Vlieghe, Esther Bartholomeus, Kerry Mullan, Wim Adriaensen, Guido Vanham, Benson Ogunjimi, Kris Laukens, Koen Vercauteren, Pieter Meysman
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Despite the general agreement on the significance of T cells during SARS-CoV-2 infection, the clinical impact of specific and cross-reactive T-cell responses remains uncertain. Understanding this aspect could provide insights for adjusting vaccines a
Externí odkaz:
https://doaj.org/article/ba2fc2c6e4b2476896a2379ad77d5b6f
Autor:
Matilde Hens, Isabel Brosius, Nicole Berens-Riha, Jasmine Coppens, Liesbeth Van Gestel, Jojanneke Rutgers, Chris Kenyon, Patrick Soentjens, Saskia van Henten, Stefanie Bracke, Thibaut Vanbaelen, Leen Vandenhoven, Emmanuel Bottieau, Koen Vercauteren, Marjan Van Esbroeck, Laurens Liesenborghs, Christophe Van Dijck, Irith De Baetselier, Dorien Van den Bossche, Eric Florence, Johan van Griensven, Maartje Van Frankenhuijsen, Marc Vandenbruaene, Veerle Huyst, Kristien Wouters, Ludwig Apers, Ilse Kint, Séverine Caluwaerts, Fien Vanroye, Jacob Verschueren, Kevin Ariën
Publikováno v:
New Microbes and New Infections, Vol 52, Iss , Pp 101093- (2023)
Background: The presentation of mpox clade IIb during the 2022 outbreak overlaps with a range of other diseases. Understanding the factors associated with mpox is important for clinical decision making. Methods: We described the characteristics of mp
Externí odkaz:
https://doaj.org/article/36ba1a97ae7f4e5d9ac95db710671d20
Autor:
Ursula Andreo, Ype P. de Jong, Margaret A. Scull, Jing W. Xiao, Koen Vercauteren, Corrine Quirk, Michiel C. Mommersteeg, Sonia Bergaya, Arjun Menon, Edward A. Fisher, Charles M. Rice
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 4, Iss 3, Pp 405-417 (2017)
Background & Aims: Hepatitis C virus (HCV) is a leading cause of chronic liver diseases and the most common indication for liver transplantation in the United States. HCV particles in the blood of infected patients are characterized by heterogeneous
Externí odkaz:
https://doaj.org/article/f81b24bdf4364b179d790a21b3bc8ca6
Publikováno v:
Viruses, Vol 8, Iss 6, p 176 (2016)
While addition of the first-approved protease inhibitors (PIs), telaprevir and boceprevir, to pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy significantly increased sustained virologic response (SVR) rates, PI-based triple the
Externí odkaz:
https://doaj.org/article/5f3b17ea32c0415bae34732bea47c734
Autor:
Laurens Liesenborghs, Veerle Huyst, Christophe Van Dijck, Jojanneke Rutgers, Irith De Baetselier, Chris Kenyon, Marjan Van Esbroeck, Koen Vercauteren
Publikováno v:
European urology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::196d4b50d6de0495006f902c8e510cc4
https://pubmed.ncbi.nlm.nih.gov/36609012
https://pubmed.ncbi.nlm.nih.gov/36609012
Autor:
Christophe Van Dijck, Irith De Baetselier, Chris Kenyon, Laurens Liesenborghs, Koen Vercauteren, Marjan Van Esbroeck, Isabel Brosius, Dorien Van den Bossche, Eric Florence, Johan van Griensven, Emmanuel Bottieau, Patrick Soentjens, Nicole Berens-Riha, Thibaut Vanbaelen, Maartje Van Frankenhuijsen, Marc Vandenbruaene, Veerle Huyst, Kristien Wouters, Ludwig Apers, Ilse Kint, Séverine Caluwaerts, Jasmine Coppens
Publikováno v:
The Lancet Microbe. 4:e132-e133
ispartof: LANCET MICROBE vol:4 issue:3 pages:e132-e133 ispartof: location:England status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ffb073d30c5b2c5f55700f920d7fac
https://doi.org/10.1016/s2666-5247(22)00357-3
https://doi.org/10.1016/s2666-5247(22)00357-3
Autor:
Ethan M. Weinberg, Michael Torbenson, Nicole J.C. Narayan, William J. Hammond, Gadi Lalazar, Ruisi Wang, Solomon Levin, Denise Ng, Michael P. LaQuaglia, Lavoisier Ramos-Espiritu, David Requena, J. Fraser Glickman, Barbara A. Lyons, Rory L. Smoot, Charles M. Rice, Eleftherios Michailidis, Jessica Ellison, Benjamin A. Farber, Erik Schadde, Hans-Guido Wendel, Koen Vercauteren, Faith Tierney, Arlene Hurley, Patrick Bhola, Mark J. Truty, Tomoaki Kato, Martin Hertl, Philip Coffino, Mohammad Kabbani, Anthony Letai, Jennifer L. Leiting, Ype P. de Jong, Bassem Shebl, Sanford M. Simon, James A. Saltsman, Michael V. Ortiz
Publikováno v:
Cancer Discov
To repurpose therapeutics for fibrolamellar carcinoma (FLC), we developed and validated patient-derived xenografts (PDX) from surgical resections. Most agents used clinically and inhibitors of oncogenes overexpressed in FLC showed little efficacy on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966cf4d6404337fbeea04a8fa44d7bd2
https://doi.org/10.1158/2159-8290.cd-20-0872
https://doi.org/10.1158/2159-8290.cd-20-0872